August 2012 Editor's Picks: Products from Getinge and MG America - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

August 2012 Editor's Picks: Products from Getinge and MG America

Equipment and Processing Report

August 2012 Editor's Picks: Products from Getinge and MG America
Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Getinge

Rigid-wall isolators improve productivity of sterility testing.
Sterility testing in an isolator helps avoid false-positive or false-negative results, and Getinge-La Calhène’s Isotest stainless-steel, rigid-wall isolators are designed to improve the workflow for sterility testing of injectables. The Isotest is equipped with one or two workstations in the same chamber, an attached fast decontamination chamber, and Getinge’s DPTE transfer system to evacuate the test canister and solid/liquid waste. The Isotest integrated bio-decontamination system is self-contained. Isotest can bio-decontaminate either the working chamber or the fast-decontamination chamber using the Isotest PLC control-system touch screen. Hydrogen peroxide is delivered from a canister that includes an RFID chip, which allows the PLC to monitor the volume and remaining shelf life, thus providing full traceability.


MG America
Versatile capsule filler with multiple dosing units is designed for small runs.

MG America’s FlexaLAB capsule filler, which can produce up to 3000 capsules per hour, is designed for research and development, clinical trials, and small-batch production. The FlexaLAB can function with either continuous or intermittent motion. Installing multiple dosing units allows the FlexaLAB to manufacture capsules with combinations of products. The machine can fill powders, pellets, microtablets, tablets, liquids, and certain low-dosage powder inhalants and can perform capsule-into-capsule functions. The machine includes a touch-screen panel and PLC for machine-functions control. Machine speed can be adjusted from the monitor.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here